Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

107 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Multicenter, Prospective, Phase II and Biomarker Study of High-Dose Bevacizumab as Induction Therapy in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannoma.
Plotkin SR, Duda DG, Muzikansky A, Allen J, Blakeley J, Rosser T, Campian JL, Clapp DW, Fisher MJ, Tonsgard J, Ullrich N, Thomas C, Cutter G, Korf B, Packer R, Karajannis MA. Plotkin SR, et al. J Clin Oncol. 2019 Dec 10;37(35):3446-3454. doi: 10.1200/JCO.19.01367. Epub 2019 Oct 18. J Clin Oncol. 2019. PMID: 31626572 Free PMC article. Clinical Trial.
Brainstem lesions in neurofibromatosis type 1.
Ullrich NJ, Raja AI, Irons MB, Kieran MW, Goumnerova L. Ullrich NJ, et al. Neurosurgery. 2007 Oct;61(4):762-6; discussion 766-7. doi: 10.1227/01.NEU.0000298904.63635.2D. Neurosurgery. 2007. PMID: 17986937
Brain tumors and epileptic spasms: Natural history and outcomes.
Benitez V, Manley PE, Goumnerova LC, Harini C, Ullrich NJ. Benitez V, et al. Among authors: ullrich nj. Epilepsy Behav. 2017 Oct;75:25-28. doi: 10.1016/j.yebeh.2017.07.036. Epub 2017 Aug 15. Epilepsy Behav. 2017. PMID: 28818811
107 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page